Scribd Logo
Upload

Welcome to Scribd!

  • 30 views

    Swot Analysis of Pharma Sector

    Uploaded by

    Karan Verma
    The pharmaceutical sector in India has many strengths including cost-effective technology, strong manufacturing capabilities, clinical research, skilled labor, and high quality standards. However, it also has weaknesses such as a low global market share, lack of strategic planning, low R&D investment, and insufficient collaboration between industry and research institutions. There are opportunities for growth through increased exports, an aging population, new products, and generics production. Threats include competition from large multinational corporations, intellectual property changes, and trade barriers imposed by other nations.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Swot Analysis of Pharma Sector

    Uploaded by

    Karan Verma
    30 views1 page
    The pharmaceutical sector in India has many strengths including cost-effective technology, strong manufacturing capabilities, clinical research, skilled labor, and high quality standards. However, it also has weaknesses such as a low global market share, lack of strategic planning, low R&D investment, and insufficient collaboration between industry and research institutions. There are opportunities for growth through increased exports, an aging population, new products, and generics production. Threats include competition from large multinational corporations, intellectual property changes, and trade barriers imposed by other nations.

    Original Description:

    Swot Analysis of Pharma Sector

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The pharmaceutical sector in India has many strengths including cost-effective technology, strong manufacturing capabilities, clinical research, skilled labor, and high quality standards. However, it also has weaknesses such as a low global market share, lack of strategic planning, low R&D investment, and insufficient collaboration between industry and research institutions. There are opportunities for growth through increased exports, an aging population, new products, and generics production. Threats include competition from large multinational corporations, intellectual property changes, and trade barriers imposed by other nations.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    30 views1 page

    Swot Analysis of Pharma Sector

    Uploaded by

    Karan Verma
    The pharmaceutical sector in India has many strengths including cost-effective technology, strong manufacturing capabilities, clinical research, skilled labor, and high quality standards. However, it also has weaknesses such as a low global market share, lack of strategic planning, low R&D investment, and insufficient collaboration between industry and research institutions. There are opportunities for growth through increased exports, an aging population, new products, and generics production. Threats include competition from large multinational corporations, intellectual property changes, and trade barriers imposed by other nations.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 1

    SWOTANALYSISOFPHARMASECTOR

    STRENGTHS:
    Cost effective technology
    Strong and well-developed manufacturing base
    Clinical research and trials
    Knowledge based, low- cost manpower in science & technology
    Proficiency in path-breaking research
    High-quality formulations and drugs
    High standards of purity
    World-class process development labs
    WEAKNESSES
    Low Indian share in world pharmaceutical market (about 2%)
    Lack of strategic planning
    Fragmented capacities
    Low R&D investments
    Absence of association between institutes and industry
    Low healthcare expenditure
    Production of duplicate drugs
    OPPORTUNITIES
    Incredible export potential
    Increasing health consciousness
    New innovative therapeutic products
    Globalization
    Drug delivery system management
    Increased incomes
    Production of generic drugs
    Contract manufacturing
    Clinical trials & research
    Drug molecules
    THREATS
    Small number of discoveries
    Competition from MNCs
    Transformation of process patent to product patent (TRIPS)
    Outdated Sales and marketing methods
    Non-tariff barriers imposed by developed countries

    You might also like